ASP Isotopes Inc. (ASPI)
NASDAQ: ASPI · Real-Time Price · USD
7.71
+0.56 (7.83%)
At close: Nov 21, 2024, 4:00 PM
7.76
+0.05 (0.64%)
After-hours: Nov 21, 2024, 5:43 PM EST
Company Description
ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes.
It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28.
The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.
ASP Isotopes Inc.
| Country | United States |
| Founded | 2021 |
| IPO Date | Nov 10, 2022 |
| Industry | Chemicals |
| Sector | Materials |
| Employees | 76 |
| CEO | Paul Mann |
Contact Details
Address: 1101 Pennsylvania Avenue NW, Suite 300 Washington, District of Columbia 20004 United States | |
| Phone | 202 756 2245 |
| Website | aspisotopes.com |
Stock Details
| Ticker Symbol | ASPI |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0001921865 |
| CUSIP Number | 00218A105 |
| ISIN Number | US00218A1051 |
| Employer ID | 87-2618235 |
| SIC Code | 2890 |
Key Executives
| Name | Position |
|---|---|
| Dr. Gerdus Kemp M.D., Ph.D. | Medical Director and Chief Executive Officer of Pet Labs |
| Robert Ainscow | Chief Operating Officer |
| Dr. Hendrik Strydom B. Sc, M. Sc, Ph.D. | Chief Technology Officer and Director |
| Heather Kiessling | Chief Financial Officer |
| Hendrik T. van Wyk | Head of Engineering |
| Dr. Xandra van Heerden Ph.D. | Head of Research and Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 20, 2024 | 8-K | Current Report |
| Nov 19, 2024 | 10-Q | Quarterly Report |
| Nov 14, 2024 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
| Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 14, 2024 | 8-K | Current Report |
| Nov 7, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 4, 2024 | 8-K | Current Report |
| Nov 4, 2024 | 424B5 | Filing |
| Nov 4, 2024 | 424B5 | Filing |
| Nov 4, 2024 | 8-K | Current Report |